| Literature DB >> 32816177 |
Savino Spadaro1, Salvatore Grasso2, Dan Stieper Karbing3, Giuseppe Santoro4, Giorgio Cavallesco5, Pio Maniscalco5, Francesca Murgolo2, Rosa Di Mussi2, Riccardo Ragazzi4, Stephen Edward Rees3, Carlo Alberto Volta4, Alberto Fogagnolo4.
Abstract
During one-lung ventilation (OLV), titrating the positive end-expiratory pressure (PEEP) to target a low driving pressure (∆P) could reduce postoperative pulmonary complications. However, it is unclear how to conduct PEEP titration: by stepwise increase starting from zero PEEP (PEEPINCREMENTAL) or by stepwise decrease after a lung recruiting manoeuvre (PEEPDECREMENTAL). In this randomized trial, we compared the physiological effects of these two PEEP titration strategies on respiratory mechanics, ventilation/perfusion mismatch and gas exchange. Patients undergoing video-assisted thoracoscopic surgery in OLV were randomly assigned to a PEEPINCREMENTAL or PEEPDECREMENTAL strategy to match the lowest ∆P. In the PEEPINCREMENTAL group, PEEP was stepwise titrated from ZEEP up to 16 cm H2O, whereas in the PEEPDECREMENTAL group PEEP was decrementally titrated, starting from 16 cm H2O, immediately after a lung recruiting manoeuvre. Respiratory mechanics, ventilation/perfusion mismatch and blood gas analyses were recorded at baseline, after PEEP titration and at the end of surgery. Sixty patients were included in the study. After PEEP titration, shunt decreased similarly in both groups, from 50 [39-55]% to 35 [28-42]% in the PEEPINCREMENTAL and from 45 [37-58]% to 33 [25-45]% in the PEEPDECREMENTAL group (both p < 0.001 vs baseline). The resulting ∆P, however, was lower in the PEEPDECREMENTAL than in the PEEPINCREMENTAL group (8 [7-11] vs 10 [9-11] cm H2O; p = 0.03). In the PEEPDECREMENTAL group the PaO2/ FIO2 ratio increased significantly after intervention (from 140 [99-176] to 186 [152-243], p < 0.001). Both the PEEPINCREMENTAL and the PEEPDECREMENTAL strategies were able to decrease intraoperative shunt, but only PEEPDECREMENTAL improved oxygenation and lowered intraoperative ΔP.Clinical trial number NCT03635281; August 2018; "retrospectively registered".Entities:
Keywords: Driving pressure; One-lung ventilation; Oxygenation; Positive end-expiratory pressure; Shunt
Mesh:
Year: 2020 PMID: 32816177 PMCID: PMC7439797 DOI: 10.1007/s10877-020-00582-z
Source DB: PubMed Journal: J Clin Monit Comput ISSN: 1387-1307 Impact factor: 2.502
Fig. 1Resume of study protocol
Characteristic’s patients
| Variable | All patients | PEEPINCREMENTAL | PEEPDECREMENTAL | p value |
|---|---|---|---|---|
| Age | 68 ± 9 | 66 ± 8 | 67 ± 9 | 0.571 |
| BMI | 27.5 ± 5.5 | 27.0 ± 6.2 | 27.8 ± 5.5 | 0.576 |
| ASA score | 0.506 | |||
| II | 11 | 4 | 7 | |
| III | 49 | 26 | 23 | |
| Sex (M/F), n | 40/20 | 18/12 | 22/8 | 0.411 |
| Surgery side (L/R) | 29/31 | 13/17 | 15/15 | 0.312 |
| Type of surgery | 0.061 | |||
| Lobectomy | 55 | 30 | 25 | |
| Wedge resection | 5 | – | 5 | |
| Duration of MV (min) | 212 [175–255] | 218 [195–255] | 205 [175–255] | 0.57 |
| Duration of OLV (min) | 192 [166–240] | 195 [180–240] | 190 [145–240] | 0.49 |
| Comorbidities | ||||
| Diabetes, n (%) | 8 (13) | 4 (13) | 4 (13) | 0.999 |
| Hypertension, n (%) | 35 (50) | 10 (33) | 16 (53) | 0.192 |
| Vascular disease, n (%) | 20 (33) | 10 (33) | 10 (33) | 0.999 |
| COPD, n (%) | 10 (16) | 6 (20) | 4 (13) | 0.731 |
| Preoperative spirometry | ||||
| FVC (% predicted) | 104 [93–117] | 99 [79–117] | 107 [96–118] | 0.204 |
| FEV1 (%) | 96 [79–109] | 90 [70–105] | 105 [86–116] | 0.061 |
| FEV1/FVC | 75 ± 12 | 77 ± 16 | 74 ± 9 | 0.75 |
| KCO (% predicted) | 74 [62–93] | 69 [58–80] | 86 [67–98] | 0.086 |
| ERV (% predicted) |
BMI body mass index, MRC Medical Research Council Scale, MV mechanical ventilation, OLV one lung ventilation, VC vital capacity, FEV1 forced expiratory volume in the 1st second, FVC forced vital capacity, MEF maximal expiratory flow, ERV expiratory reserve volume
p values are referred to comparison between PEEPINCREMENTAL and PEEPDECREMENTAL group
Mechanical ventilation variables and V̇/Q̇ measurement during the study period
| Variable | TLV, after induction | OLV, prior to intervention | OLV, after intervention | TLV, End of surgery | ||||
|---|---|---|---|---|---|---|---|---|
| PEEPINCREMENTAL | PEEPDECREMENTAL | PEEPINCREMENTAL | PEEPDECREMENTAL | PEEPINCREMENTAL | PEEPDECREMENTAL | PEEPINCREMENTAL | PEEPDECREMENTAL | |
| Mechanical ventilation | ||||||||
| Paw (cm H2O) | 20 [15–23] | 18 [14–20.5] | 23 [19.5–27.5] | 22 [20–26] | 25.5 [22.2–30] | 24 [23–29] | 24.5 [20.7–28.2] | 18 [14–20.5] |
| Plateau pressure (cm H2O) | 13 [10–15] | 13 [10–15] | 15 [14–19] | 15 [14–19] | 19 [17–22] | 17.5 [15–21] | 19 [16–22] | 18 [15–20] |
| Driving Pressure (cm H2O) | 13 [10–15] | 12 [10–16] | 15 [14–19] | 14 [13–19] | 10 [8–12] | 9 [7–12] | ||
| PEEP (cm H2O) | 0 | 0 | 0 | 0 | 8 [6–12] | 8 [8–10] | 8 [6–12] | 8 [8–10] |
| Tidal volume | 440 [385–500] | 440 [400–490] | 315 [270–350] | 310 [290–350] | 315 [270–350] | 310 [290–350] | 440 [390–500] | 440 [400–490] |
| Respiratory rate | 14 [14–15] | 14 [13–15] | 16 [14–16] | 16 [14–16] | 16 [14.2–17.5] | 16 [16–18] | 16 [14–16] | 16 [14–17] |
| Mechanical power (J/m) | 10.8 [8.6–12.4] | 9.5 [8.1–12.7] | 5.6 [4.5–6.8] | 5.8 [4.4–6.6] | 12.8 [10.0–16.1] | 13.3 [11.4–15.0] | ||
| V/Q̇ variables | ||||||||
| Shunt (%) | 26.2 [21.8–32.9] | 24.0 [16.1–33.1] | 49.8 [39.0–55.0] | 45.2 [37.5–58.1] | 18.6 [9.0–25.2] | 18.5 [9.8–22.6] | ||
| Low V̇/Q̇ (mmHg) | 39 [17–65] | 35 [23–71] | 86 [37–150] | 69 [23–144] | 55 [38–75] | 57 [34–101] | 28 [22–70] | 35 [24–72] |
| High V̇/Q̇ (mmHg) | 11 [6–15] | 11 [6–15] | 13 [10–16] | 11 [7–15] | 13 [11–18] | 13 [6.7–17] | 12 [10–16] | 12 [7–17] |
Paw Peak airway pressure, PEEP positive end-expiratory pressure; V̇/Q̇ = Ventilation/perfusion ratio
#p < 0.05 vs the other group, *p < 0.05 vs prior to intervention
Fig. 2Shunt evaluation during the study in the PEEPINCREMENTAL and PEEPDECREMENTAL group
Fig. 3Individual changes in driving pressure before and after the study intervention in the PEEPINCREMENTAL and PEEPDECREMENTAL group
Blood gas analysis during the study period
| Variable | TLV, after induction | OLV, prior to intervention | OLV, after intervention | TLV, End of surgery | ||||
|---|---|---|---|---|---|---|---|---|
| PEEPINCREMENTAL | PEEPDECREMENTAL | PEEPINCREMENTAL | PEEPDECREMENTAL | PEEPINCREMENTAL | PEEPDECREMENTAL | PEEPINCREMENTAL | PEEPDECREMENTAL | |
| PaO2/FIO2 ratio (mmHg) | 350 [238–438] | 298 [219–447] | 139 [103–202] | 140 [99–176] | 153 [103–192] | 423 [241–492] | 402 [262–463] | |
| FIO2 | 50 [40–55] | 40 [40–50] | 58 [49–66] | 55 [49–60] | 57 [50–65] | 50 [44–60] | ||
| PaCO2 (mmHg) | 47 [42–51] | 38 [42–52] | 55 [50–59] | 53 [49–60] | 59 [54–62] | 54 [51–64] | 49 [45–52] | 50 [43–53] |
| pH | 7.36 ± 0.05 | 7.36 ± 0.05 | 7.31 ± 0.05 | 7.31 ± 0.07 | 7.27 ± 0.05* | 7.28 ± 0.06* | 7.31 ± 0.04 | 7.31 ± 0.06 |
| HCO3− | 26.9 ± 2.6 | 26.5 ± 2.5 | 27.0 ± 1.8 | 26.7 ± 2.3 | 26.4 ± 1.7 | 26.3 ± 2.5 | 24.7 ± 1.9 | 24.4 ± 2.3 |
| Lactate (mmol/L) | 1 [0.7–1.2] | 0.8 [0.7–1.2] | 0.8 [0.7–1.2] | 0.8 [0.7–1.1] | 0.8 [0.6–1] | 0.8 [0.7–1.1] | 0.9 [0.7–1.0] | 0.8 [0.7–1.0] |
| Hb (g/dL) | 12.6 ± 1.8 | 12.4 ± 1.6 | 12.1 ± 1.6 | 12.0 ± 1.6 | 12.1 ± 1.7 | 11.9 ± 1.6 | 12.0 ± 1.9 | 11.5 ± 1.7 |
Pa arterial partial pressure of carbon dioxide, Pa arterial partial pressure of oxygen, FO fraction of inspired oxygen, Hb hemoglobin
#p < 0.05 vs the other group, *p < 0.05 vs prior to intervention